Carbapenem-resistant Enterobacteriaceae: What we know and what we need to know

Por van Duin, David
Publicado no Virulence (2017)

Diagnostic Challenges and Opportunities in Older Adults With Infectious Diseases

Por van Duin, David
Publicado no Clin Infect Dis (2012)

Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients

Por PEREZ, FEDERICO, VAN DUIN, DAVID
Publicado em 2013

Outbreak of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae: Are We at the End of the Road?

Por van Duin, David, Doi, Yohei
Publicado no J Clin Microbiol (2015)

Multidrug Resistant Bacteria in the Community: Trends and Lessons Learned

Por van Duin, David, Paterson, David
Publicado no Infect Dis Clin North Am (2016)

Novel Beta-lactamase Inhibitors: Unlocking Their Potential in Therapy

Por Wong, Darren, van Duin, David
Publicado no Drugs (2017)

The global epidemiology of carbapenemase-producing Enterobacteriaceae

Por van Duin, David, Doi, Yohei
Publicado no Virulence (2016)

Polymyxin Resistance in Klebsiella pneumoniae: Complexity at Every Level

Por Doi, Yohei, van Duin, David
Publicado no Clin Infect Dis (2020)

Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations

Por van Duin, David, Bonomo, Robert A.
Publicado no Clin Infect Dis (2016)

Reply to Elamin et al

Por Lachiewicz, Anne M, van Duin, David
Publicado no Clin Infect Dis (2018)

Current trends in the treatment of pneumonia due to multidrug-resistant Gram-negative bacteria

Por Watkins, Richard R., Van Duin, David
Publicado no F1000Res (2019)

Reply to Macesic et al

Por van Duin, David, Bonomo, Robert A.
Publicado no Clin Infect Dis (2017)

Cytomegalovirus Viremia, Pneumonitis, and Tocilizumab Therapy

Por van Duin, David, Miranda, Cyndee, Husni, Elaine
Publicado em 2011

The impact of the COVID-19 pandemic on antimicrobial resistance: a debate

Por van Duin, David, Barlow, Gavin, Nathwani, Dilip
Publicado no JAC Antimicrob Resist (2020)

Melanization of Cryptococcus neoformans and Histoplasma capsulatum Reduces Their Susceptibilities to Amphotericin B and Caspofungin

Por van Duin, David, Casadevall, Arturo, Nosanchuk, Joshua D.
Publicado em 2002

Antimicrobial Resistance in Enterobacterales and Its Contribution to Sepsis in Sub-saharan Africa

Por Tompkins, Kathleen, Juliano, Jonathan J., van Duin, David
Publicado no Front Med (Lausanne) (2021)

Experience with Fosfomycin for Treatment of Urinary Tract Infections Due to Multidrug-Resistant Organisms

Por Neuner, Elizabeth A., Sekeres, Jennifer, Hall, Gerri S., van Duin, David
Publicado em 2012

Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes,

Por van Duin, David, Kaye, Keith S., Neuner, Elizabeth A., Bonomo, Robert A.
Publicado em 2013

Carbapenem-Resistant Klebsiella pneumoniae Urinary Tract Infection following Solid Organ Transplantation

Por Brizendine, Kyle D., Richter, Sandra S., Cober, Eric D., van Duin, David
Publicado no Antimicrob Agents Chemother (2014)

Endemic Mycoses in Solid Organ Transplant Recipients

Por Nel, Jeremy S., Bartelt, Luther A., van Duin, David, Lachiewicz, Anne M.
Publicado no Infect Dis Clin North Am (2018)